S&P 500   0.52 (-8.53%)
DOW   0.52 (-8.53%)
QQQ   270.38 (+0.37%)
AAPL   438.66 (+0.67%)
MSFT   213.29 (-1.50%)
FB   249.83 (-0.85%)
GOOGL   1,473.30 (-0.64%)
AMZN   3,138.83 (+0.87%)
NVDA   449.11 (+1.98%)
CGC   19.32 (+1.36%)
BABA   262.20 (+1.65%)
TSLA   1,487.00 (+0.13%)
MU   51.30 (+1.81%)
GE   6.14 (+0.49%)
AMD   85.04 (+9.49%)
T   30.01 (+1.32%)
F   6.86 (+2.54%)
ACB   10.73 (+2.98%)
GILD   70.88 (-1.18%)
NFLX   509.64 (+2.21%)
DIS   117.29 (+0.81%)
BAC   25.01 (+0.08%)
BA   165.07 (+1.73%)
S&P 500   0.52 (-8.53%)
DOW   0.52 (-8.53%)
QQQ   270.38 (+0.37%)
AAPL   438.66 (+0.67%)
MSFT   213.29 (-1.50%)
FB   249.83 (-0.85%)
GOOGL   1,473.30 (-0.64%)
AMZN   3,138.83 (+0.87%)
NVDA   449.11 (+1.98%)
CGC   19.32 (+1.36%)
BABA   262.20 (+1.65%)
TSLA   1,487.00 (+0.13%)
MU   51.30 (+1.81%)
GE   6.14 (+0.49%)
AMD   85.04 (+9.49%)
T   30.01 (+1.32%)
F   6.86 (+2.54%)
ACB   10.73 (+2.98%)
GILD   70.88 (-1.18%)
NFLX   509.64 (+2.21%)
DIS   117.29 (+0.81%)
BAC   25.01 (+0.08%)
BA   165.07 (+1.73%)
S&P 500   0.52 (-8.53%)
DOW   0.52 (-8.53%)
QQQ   270.38 (+0.37%)
AAPL   438.66 (+0.67%)
MSFT   213.29 (-1.50%)
FB   249.83 (-0.85%)
GOOGL   1,473.30 (-0.64%)
AMZN   3,138.83 (+0.87%)
NVDA   449.11 (+1.98%)
CGC   19.32 (+1.36%)
BABA   262.20 (+1.65%)
TSLA   1,487.00 (+0.13%)
MU   51.30 (+1.81%)
GE   6.14 (+0.49%)
AMD   85.04 (+9.49%)
T   30.01 (+1.32%)
F   6.86 (+2.54%)
ACB   10.73 (+2.98%)
GILD   70.88 (-1.18%)
NFLX   509.64 (+2.21%)
DIS   117.29 (+0.81%)
BAC   25.01 (+0.08%)
BA   165.07 (+1.73%)
S&P 500   0.52 (-8.53%)
DOW   0.52 (-8.53%)
QQQ   270.38 (+0.37%)
AAPL   438.66 (+0.67%)
MSFT   213.29 (-1.50%)
FB   249.83 (-0.85%)
GOOGL   1,473.30 (-0.64%)
AMZN   3,138.83 (+0.87%)
NVDA   449.11 (+1.98%)
CGC   19.32 (+1.36%)
BABA   262.20 (+1.65%)
TSLA   1,487.00 (+0.13%)
MU   51.30 (+1.81%)
GE   6.14 (+0.49%)
AMD   85.04 (+9.49%)
T   30.01 (+1.32%)
F   6.86 (+2.54%)
ACB   10.73 (+2.98%)
GILD   70.88 (-1.18%)
NFLX   509.64 (+2.21%)
DIS   117.29 (+0.81%)
BAC   25.01 (+0.08%)
BA   165.07 (+1.73%)
Log in

NASDAQ:WBAWalgreens Boots Alliance Stock Price, Forecast & News

$40.93
-0.15 (-0.37 %)
(As of 08/4/2020 04:00 PM ET)
Add
Compare
Today's Range
$40.48
Now: $40.93▼
$41.07
50-Day Range
$39.01
MA: $41.36▼
$44.13
52-Week Range
$36.65
Now: $40.93▼
$64.50
Volume5.78 million shs
Average Volume7.05 million shs
Market Capitalization$35.47 billion
P/E Ratio49.92
Dividend Yield4.45%
Beta0.51
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics. It also provides specialty pharmacy services and mail services; and manages in-store clinics. As of August 31, 2018, this segment operated 9,560 retail stores under the Walgreens and Duane Reade brands in the United States; and 7 specialty pharmacies, as well as approximately 400 in-store clinic locations. The Retail Pharmacy International segment sells prescription drugs; and health, beauty, personal care, and other consumer products through its pharmacy-led health and beauty stores and optical practices, as well as through boots.com and an integrated mobile application. This segment operated 4,767 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 618 optical practices, including 167 on a franchise basis. The Pharmaceutical Wholesale segment engages in the wholesale and distribution of specialty and generic pharmaceuticals, health and beauty products, and home healthcare supplies and equipment, as well as provides related services to pharmacies and other healthcare providers. This segment operates in the United Kingdom, Germany, France, Turkey, Spain, the Netherlands, Egypt, Norway, Romania, the Czech Republic, and Lithuania. The company has a strategic partnership with Microsoft Corporation. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.
Read More
Walgreens Boots Alliance logo

Beat the Market (BTM) Rank™

Analyst Opinion: 3.0Community Rank: 2.7Dividend Strength: 5.0Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

2.58 out of 5 stars


Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Drug stores & proprietary stores
Sub-IndustryDrug Retail
SectorRetail/Wholesale
Current SymbolNASDAQ:WBA
Previous Symbol
CUSIP93142210
CIK1618921
Webwww.walgreensbootsalliance.com
Phone847-315-2500

Debt

Debt-to-Equity Ratio0.57
Current Ratio0.69
Quick Ratio0.33

Price-To-Earnings

Trailing P/E Ratio49.92
Forward P/E Ratio8.75
P/E Growth1.74

Sales & Book Value

Annual Sales$136.87 billion
Price / Sales0.26
Cash Flow$8.42 per share
Price / Cash Flow4.86
Book Value$26.74 per share
Price / Book1.53

Profitability

EPS (Most Recent Fiscal Year)$5.99
Net Income$3.98 billion
Net Margins0.55%
Return on Equity19.43%
Return on Assets5.46%

Miscellaneous

Employees342,000
Outstanding Shares866,534,000
Market Cap$35.47 billion
Next Earnings Date10/26/2020 (Estimated)
OptionableOptionable
$40.93
-0.15 (-0.37 %)
(As of 08/4/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive WBA News and Ratings via Email

Sign-up to receive the latest news and ratings for WBA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Walgreens Boots Alliance (NASDAQ:WBA) Frequently Asked Questions

How has Walgreens Boots Alliance's stock been impacted by COVID-19 (Coronavirus)?

Walgreens Boots Alliance's stock was trading at $46.07 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, WBA shares have decreased by 11.2% and is now trading at $40.93.
View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Walgreens Boots Alliance?

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Walgreens Boots Alliance in the last year. There are currently 1 sell rating and 14 hold ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Walgreens Boots Alliance.

When is Walgreens Boots Alliance's next earnings date?

Walgreens Boots Alliance is scheduled to release its next quarterly earnings announcement on Monday, October 26th 2020.
View our earnings forecast for Walgreens Boots Alliance.

How were Walgreens Boots Alliance's earnings last quarter?

Walgreens Boots Alliance Inc (NASDAQ:WBA) released its earnings results on Thursday, July, 9th. The pharmacy operator reported $0.83 earnings per share for the quarter, missing the Zacks' consensus estimate of $1.10 by $0.27. The pharmacy operator had revenue of $34.63 billion for the quarter, compared to analyst estimates of $34.32 billion. Walgreens Boots Alliance had a return on equity of 19.43% and a net margin of 0.55%. The firm's quarterly revenue was up .1% compared to the same quarter last year. During the same period in the prior year, the company posted $1.47 earnings per share.
View Walgreens Boots Alliance's earnings history.

How often does Walgreens Boots Alliance pay dividends? What is the dividend yield for Walgreens Boots Alliance?

Walgreens Boots Alliance announced a quarterly dividend on Thursday, July 9th. Stockholders of record on Wednesday, August 19th will be given a dividend of $0.4675 per share on Friday, September 11th. This represents a $1.87 dividend on an annualized basis and a yield of 4.57%. The ex-dividend date of this dividend is Tuesday, August 18th. This is a boost from Walgreens Boots Alliance's previous quarterly dividend of $0.46.
View Walgreens Boots Alliance's dividend history.

What guidance has Walgreens Boots Alliance issued on next quarter's earnings?

Walgreens Boots Alliance updated its FY20 earnings guidance on Thursday, July, 9th. The company provided earnings per share (EPS) guidance of $4.65-4.75 for the period, compared to the Thomson Reuters consensus estimate of $5.49.

What price target have analysts set for WBA?

15 equities research analysts have issued 12 month target prices for Walgreens Boots Alliance's stock. Their forecasts range from $38.00 to $61.00. On average, they expect Walgreens Boots Alliance's share price to reach $46.29 in the next year. This suggests a possible upside of 13.1% from the stock's current price.
View analysts' price targets for Walgreens Boots Alliance.

Has Walgreens Boots Alliance been receiving favorable news coverage?

Headlines about WBA stock have been trending somewhat positive recently, according to InfoTrie Sentiment. The research group identifies positive and negative press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Walgreens Boots Alliance earned a news sentiment score of 0.8 on InfoTrie's scale. They also assigned media coverage about the pharmacy operator a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the near term.
View the latest news about Walgreens Boots Alliance.

Are investors shorting Walgreens Boots Alliance?

Walgreens Boots Alliance saw a increase in short interest during the month of June. As of June 30th, there was short interest totaling 18,290,000 shares, an increase of 18.2% from the June 15th total of 15,470,000 shares. Based on an average daily volume of 7,010,000 shares, the short-interest ratio is currently 2.6 days. Currently, 2.5% of the shares of the stock are sold short.
View Walgreens Boots Alliance's Current Options Chain.

Who are some of Walgreens Boots Alliance's key competitors?

Some companies that are related to Walgreens Boots Alliance include CVS Health (CVS), Covetrus (CVET), Rite Aid (RAD), Petmed Express (PETS), 111 (YI), China Jo-Jo Drugstores (CJJD), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).
View all competitors.

What other stocks do shareholders of Walgreens Boots Alliance own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Walgreens Boots Alliance investors own include AT&T (T), CVS Health (CVS), Intel (INTC), Walt Disney (DIS), Johnson & Johnson (JNJ), General Electric (GE), Verizon Communications (VZ), Cisco Systems (CSCO), AbbVie (ABBV) and Exxon Mobil (XOM).

Who are Walgreens Boots Alliance's key executives?

Walgreens Boots Alliance's management team includes the following people:
  • Mr. James A. Skinner, Exec. Chairman (Age 75)
  • Mr. Stefano Pessina, Exec. Vice Chairman & CEO (Age 78)
  • Mr. James Kehoe, Global Controller, CAO, Exec. VP & Global CFO (Age 57)
  • Mr. Alexander W. Gourlay, Co-Chief Operating Officer (Age 59)
  • Ms. Ornella Barra, Co-Chief Operating Officer (Age 66)

What is Walgreens Boots Alliance's stock symbol?

Walgreens Boots Alliance trades on the NASDAQ under the ticker symbol "WBA."

Who are Walgreens Boots Alliance's major shareholders?

Walgreens Boots Alliance's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Sumitomo Mitsui Trust Holdings Inc. (0.50%), ProShare Advisors LLC (0.31%), First Trust Advisors LP (0.23%), Schafer Cullen Capital Management Inc (0.22%), New York State Teachers Retirement System (0.13%) and Raymond James & Associates (0.12%). Company insiders that own Walgreens Boots Alliance stock include Kathleen Wilson-Thompson, Kimberly R Scardino, Marco Patrick Anthony Pagni, Nancy M Schlichting, Ornella Barra and William C Foote.
View institutional ownership trends for Walgreens Boots Alliance.

Which institutional investors are selling Walgreens Boots Alliance stock?

WBA stock was sold by a variety of institutional investors in the last quarter, including State of Michigan Retirement System, Cullen Capital Management LLC, Raymond James & Associates, QV Investors Inc., DAVENPORT & Co LLC, Stone Ridge Asset Management LLC, CWM LLC, and Front Barnett Associates LLC.
View insider buying and selling activity for Walgreens Boots Alliance.

Which institutional investors are buying Walgreens Boots Alliance stock?

WBA stock was acquired by a variety of institutional investors in the last quarter, including Sumitomo Mitsui Trust Holdings Inc., Mn Services Vermogensbeheer B.V., First Trust Advisors LP, PGGM Investments, Raymond James Financial Services Advisors Inc., Robeco Institutional Asset Management B.V., Pacer Advisors Inc., and Exchange Traded Concepts LLC.
View insider buying and selling activity for Walgreens Boots Alliance.

How do I buy shares of Walgreens Boots Alliance?

Shares of WBA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Walgreens Boots Alliance's stock price today?

One share of WBA stock can currently be purchased for approximately $40.93.

How big of a company is Walgreens Boots Alliance?

Walgreens Boots Alliance has a market capitalization of $35.47 billion and generates $136.87 billion in revenue each year. The pharmacy operator earns $3.98 billion in net income (profit) each year or $5.99 on an earnings per share basis. Walgreens Boots Alliance employs 342,000 workers across the globe.

What is Walgreens Boots Alliance's official website?

The official website for Walgreens Boots Alliance is www.walgreensbootsalliance.com.

How can I contact Walgreens Boots Alliance?

Walgreens Boots Alliance's mailing address is 108 Wilmot Road, Deerfield IL, 60015. The pharmacy operator can be reached via phone at 847-315-2500 or via email at [email protected]

This page was last updated on 8/4/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.